Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 12, 2008 10:32:11 AM CDT



Pharma, Tech Kill Early Gains

Posted Jul 21, 08 3:40 PM CDT in Business 

(Newser) – The markets failed to hold on to early-session gains today as oil rose above $131 per barrel and the overall economic outlook remained downcast, MarketWatch reports. The Dow lost 29.23 points to close at 11,467.34, the Nasdaq fell 3.25 to 2,279.53, and the S&P 500 dropped just 0.68, settling at 1,260.00.

Bank of America advanced after reporting a 41% decline in profits that nonetheless bested expectations. Pharmaceutical giant Merck saw today’s biggest fall, 6.2%, after a Norwegian report discredited cholesterol drug Vytorin. The tech sector remained moribund in the wake of last week’s poor results from Google, AMD, and Microsoft. “We could probably go a few more weeks like this before we get a true round of capitulation in August,” one analyst said.

Sources MarketWatch, Wall Street Journal

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
Schering-Plough Corp provided this undated file photo of the cholesterol-lowering drug Vytorin a product of a joint venture between pharmaceutical companies Merck & Co., and Schering-Plough Corp. Drugmakers...   (AP Photo)
A person walks past a Bank of America ATM in Charlotte, N.C., Friday, July 18, 2008. Bank of America says its second-quarter profit fell 41 percent, as credit quality continued to weaken.   (AP Photo/Chuck Burton)
Traders work on the floor of the New York Stock Exchange in this undated file photo.   (AP Photo/Edouard H.R. Gluck)
« Prev« Prev | Next »Next » Slideshow

Threads (
1
 of 2)



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Business Stories


What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »